Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | USP5 | P45974 | 1/20 | 0.35 |
| ▸ | MLYCD | O95822 | 5/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.35 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28516564 | 0.87 | ABCB11 (0.38) | ABCB11TRPA1ACHEUSP5MLYCD | |
| SCHEMBL10050671 | 0.86 | ALDH1A1 (0.46) | CYP2C9 | |
| SCHEMBL11931417 | 0.82 | TSHR (0.37) | MLYCD | |
| SCHEMBL54909 | 0.81 | CYP2C9 (0.50) | USP5CYP2D6CYP2C9HIF1APOLB | |
| SCHEMBL4197514 | 0.81 | ESR1 (0.43) | USP5MLYCDCYP2D6CYP2C9HIF1A | |
| SCHEMBL8516775 | 0.80 | MLYCD (0.42) | MLYCDCYP2C9POLB | |
| SCHEMBL537689 | 0.79 | PTPN5 (0.38) | USP5MLYCDCYP2D6CYP2C9HIF1A | |
| SCHEMBL4941665 | 0.79 | ESR1 (0.40) | USP5MLYCDCYP2C9POLB | |
| SCHEMBL4417603 | 0.79 | MLYCD (0.35) | USP5MLYCDNR1H4 | |
| SCHEMBL10778919 | 0.79 | STAT3 (0.38) | ACHEUSP5MLYCDGRIA4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7887176-B2 | High image quality in inkjet printing onto flexible packaging substrates of polyester, polypropylene, and aluminum foil, can be significantly improved by the use of radiation curable gel based phase change inks; not requiring pinning of the ink during color printing or nitrogen inerting during curing | XEROX CORPORATION (US) | 2011-02-15 | — | — | US | disclosed |
| US-7625956-B2 | Phase change inks containing photoinitiator with phase change properties and gellant affinity | XEROX CORPORATION (US) | 2009-12-01 | — | — | US | disclosed |
| EP-1763499-B1 | NEW PHOTOINITIATORS | CIBA SC HOLDING AG (CH) | 2007-09-26 | — | — | EP | disclosed |